Method of applying energy to tissue with expandable ligator catheter having multiple electrode leads

Abstract
A catheter includes a plurality of primary leads to deliver energy for ligating a hollow anatomical structure. Each of the primary leads includes an electrode located at the working end of the catheter. Separation is maintained between the primary leads such that each primary lead can individually receive power of selected polarity. The primary leads are constructed to expand outwardly to place the electrodes into apposition with an anatomical structure. High frequency energy can be applied from the leads to create a heating effect in the surrounding tissue of the anatomical structure. The diameter of the hollow anatomical structure is reduced by the heating effect, and the electrodes of the primary leads are moved closer to one another. Where the hollow anatomical structure is a vein, energy is applied until the diameter of the vein is reduced to the point where the vein is occluded. In one embodiment, a secondary lead is surrounded by the primary leads, and extends beyond the primary leads. The secondary lead includes an electrode at the working end of the catheter. The secondary lead can have a polarity opposite to the polarity of the primary leads in a bipolar configuration. The polarity of the leads can be switched and the catheter can be moved during treatment to ligate an extended length of the vein. The catheter can include a lumen to accommodate a guide wire or to allow fluid delivery.
Description




BACKGROUND OF THE INVENTION




The invention relates generally to a method and apparatus for applying energy to shrink a hollow anatomical structure such as a vein, and more particularly, to a method and apparatus using an electrode device having multiple leads for applying said energy.




The human venous system of the lower limbs consists essentially of the superficial venous system and the deep venous system with perforating veins connecting the two systems. The superficial system includes the long or great saphenous vein and the short saphenous vein. The deep venous system includes the anterior and posterior tibial veins which unite to form the popliteal vein, which in turn becomes the femoral vein when joined by the short saphenous vein.




The venous system contains numerous one-way valves for directing blood flow back to the heart. Venous valves are usually bicuspid valves, with each cusp forming a sack or reservoir for blood which, under retrograde blood pressure, forces the free surfaces of the cusps together to prevent retrograde flow of the blood and allows only antegrade blood flow to the heart. When an incompetent valve is in the flow path, the valve is unable to close because the cusps do not form a proper seal and retrograde flow of the blood cannot be stopped. When a venous valve fails, increased strain and pressure occur within the lower venous sections and overlying tissues, sometimes leading to additional valvular failure. Two venous conditions which often result from valve failure are varicose veins and more symptomatic chronic venous insufficiency.




The varicose vein condition includes dilation and tortuosity of the superficial veins of the lower limbs, resulting in unsightly discoloration, pain, swelling, and possibly ulceration. Varicose veins often involve incompetence of one or more venous valves, which allow reflux of blood within the superficial system. This can also worsen deep venous reflux and perforator reflux. Current treatments of vein insufficiency include surgical procedures such as vein stripping, ligation, and occasionally, vein-segment transplant.




Ligation involves the cauterization or coagulation of vascular lumina using electrical energy applied through an electrode device. An electrode device is introduced into the vein lumen and positioned so that it contacts the vein wall. Once properly positioned, RF energy is applied to the electrode device thereby causing the vein wall to shrink in cross-sectional diameter. A reduction in cross-sectional diameter, as for example from 5 mm (0.2 in) to 1 mm (0.04 in), significantly reduces the flow of blood through the vein and results in an effective ligation. Though not required for effective ligation, the vein wall may completely collapse thereby resulting in a full-lumen obstruction that blocks the flow of blood through the vein.




One apparatus for performing venous ligation includes a tubular shaft having an electrode device attached at the distal tip. Running through the shaft, from the distal end to the proximal end, are electrical leads. At the proximal end of the shaft, the leads terminate at an electrical connector, while at the distal end of the shaft the leads are connected to the electrode device. The electrical connector provides the interface between the leads and a power source, typically an RF generator. The RF generator operates under the guidance of a control device, usually a microprocessor.




The ligation apparatus may be operated in either a monopolar and bipolar configuration. In the monopolar configuration, the electrode device consists of an electrode that is either positively or negatively charged. A return path for the current passing through the electrode is provided externally from the body, as for example by placing the patient in physical contact with a large low-impedance pad. The current flows from the ligation device to the low impedance pad. In a bipolar configuration, the electrode device consists of a pair of oppositely charged electrodes separated by a dielectric material. Accordingly, in the bipolar mode, the return path for current is provided by the electrode device itself. The current flows from one electrode, through the tissue, and returns by way of the oppositely charged electrode.




To protect against tissue damage; i.e., charring; due to cauterization caused by overheating, a temperature sensing device is attached to the electrode device. The temperature sensing device may be a thermocouple that monitors the temperature of the, venous tissue. The thermocouple interfaces with the RF generator and the controller through the shaft and provides electrical signals to the controller which monitors the temperature and adjusts the energy applied to the tissue, through the electrode device, accordingly.




The overall effectiveness of a ligation apparatus is largely dependent on the electrode device contained within the apparatus. Monopolar and bipolar electrode devices that comprise solid devices having a fixed shape and size limit the effectiveness of the ligating apparatus for several reasons. Firstly, a fixed-size electrode device typically contacts the vein wall at only one point on the circumference or inner diameter of the vein wall. As a result, the application of RF energy is highly concentrated within the contacting venous tissue, while the flow of RF current through the remainder of the venous tissue is disproportionately weak. Accordingly, the regions of the vein wall near the point of contact collapse at a faster rate then other regions of the vein wall, resulting in non-uniform shrinkage of the vein lumen. Furthermore, the overall strength of the occlusion may be inadequate and the lumen may eventually reopen. To avoid an inadequate occlusion RF energy must be applied for an extended period of time. Application of RF energy as such increases the temperature of the blood and usually results in a significant amount of heat-induced coagulum forming on the electrode and in the vein which is not desirable.




Secondly, the effectiveness of a ligating apparatus having a fixed electrode device is limited to certain sized veins. An attempt to ligate a vein having a diameter that is substantially greater than the electrode device can result in not only non-uniform shrinkage of the vein wall as just described, but also insufficient shrinkage of the vein. The greater the diameter of the vein relative to the diameter of the electrode device, the weaker the energy applied to the vein wall at points distant from the point of contact. Accordingly the vein wall is likely to not completely collapse prior to the venous tissue becoming over cauterized at the point of electrode contact. While coagulation as such may initially occlude the vein, such occlusion may only be temporary in that the coagulated blood may eventually dissolve and the vein partially open. One solution for this inadequacy is an apparatus having interchangeable electrode devices with various diameters. Such a solution, however, is both economically inefficient and tedious to use.




Hence those skilled in the art have recognized a need for an expandable electrode device and a method capable of evenly distributing RF energy along a circumferential band of a vein wall where the vein wall is greater in diameter than the electrode device, and thereby provide more predictable and effective occlusion of veins while minimizing the formation of heat-induced coagulum. The invention fulfills these needs and others.




SUMMARY OF THE INVENTION




Briefly, and in general terms, the present invention provides an apparatus and method for applying energy along a generally circumferential band of a vein wall. The application of energy as such results in a more uniform and predictable shrinkage of the vein wall.




In one aspect of the invention, an apparatus for delivering energy to ligate an anatomical structure comprises a catheter having a sheath, a working end, and an opening formed at the working end of the catheter; an inner member disposed within the sheath such that the inner member and the sheath are capable of being moved relative to one another; a plurality of leads, each lead having a distal end, the plurality of leads being coupled with the inner member such that the distal ends of the plurality of leads extend out of the opening at the working end of the catheter when the position of the sheath changes in one direction relative to the inner member, each lead being formed to move the distal end away from a longitudinal axis defined by the sheath when the plurality of leads are extended out the opening; wherein the distal ends of the leads are configured to deliver energy to the anatomical structure.




In another aspect of the invention, the apparatus includes a secondary lead having a secondary distal end. The secondary lead is coupled with the inner member such that the distal end of the secondary lead is extended out of the opening at the working end of the catheter when the position of the inner member changes in one direction relative to the sheath.




In another aspect of the invention, the distal ends of the leads are electrically connected to a power source such that the polarity of each lead can be switched. Where there is a secondary lead electrode, the plurality of leads can be connected to the power source such that the polarity of the leads can be changed independently of the polarity of the secondary lead.




In another aspect, the leads include primary leads which generally surround the secondary lead at the working end of the catheter. The distal ends of the primary leads are located between the distal end of the secondary lead and the inner member.




In yet another aspect, the invention comprises a method of applying energy to a hollow anatomical structure from within the structure. The method includes the step of introducing a catheter into the anatomical structure; the catheter having a working end and a plurality of leads, each lead having a distal end, and each lead being connected to a power source. The method also includes the step of expanding the leads outwardly through the distal orifice and expanding the leads until each electrode contacts the anatomical structure. The method further includes the step of applying energy to the anatomical structure from the distal end of the leads, until the anatomical structure collapses.




In another aspect of the invention, the method also includes the step of introducing a catheter into the anatomical structure where the catheter has a secondary lead that has a distal portion that is greater in length than the primary-lead distal portions and is generally surrounded by the primary leads. The secondary lead also has an electrode at the distal end. The method also includes the steps of extending the primary and secondary leads through the orifice until each primary-lead electrode contacts the anatomical structure, and controlling the power source so that adjacent primary leads are of opposite polarity while maintaining the secondary-lead so that it is electrically neutral. Upon collapse of the anatomical structure around the primary leads, the polarity of the primary leads is switched so that they are all of the same polarity. Upon switching the polarity of the primary leads so that they are of the same polarity, controlling the power source so that the secondary lead is of opposite polarity relative to the primary leads. The method, in a further aspect, comprises the step of moving the catheter in the anatomical structure while continuing to apply energy to the anatomical structure to lengthen the area of ligation.




In another aspect of the invention, external compression is used to initially force the wall of the vein to collapse toward the catheter. The application of energy molds the vein to durably assume the collapsed state initially achieved mechanically by the external compression. A tourniquet can be used to externally compress or flatten the anatomical structure and initially reduce the diameter of the hollow anatomical structure. The pressure applied by the tourniquet can exsanguinate blood from the venous treatment site, and pre-shape the vein in preparation to be molded to a ligated state. An ultrasound window formed in the tourniquet can be used to facilitate ultrasound imaging of the anatomical structure being treated through the window.




These and other aspects and advantages of the present invention will become apparent from the following more detailed description, when taken in conjunction with the accompanying drawings which illustrate, by way of example, embodiments of the invention.











BRIEF DESCRIPTION OF THE DRAWINGS





FIG. 1

is a diagram of an energy application system with a partial cutaway view of a catheter showing both the working end and the connecting end and incorporating a preferred embodiment of the present invention;





FIG. 2

is a cross-sectional view of the working end of a first embodiment of a catheter in accordance with the invention depicting the electrodes in a fully extended position;





FIG. 2



a


is an end view of the working end of the first embodiment of the catheter taken along line


2




a





2




a


of

FIG. 2

;





FIG. 3

is a cross-sectional view of the working end of the first embodiment depicting the electrodes in a fully retracted position;





FIG. 4

is a cross-sectional view of the working end of a second catheter in accordance with principles of the invention depicting the electrodes in a fully extended position;





FIG. 4



a


is an end view of the second embodiment of the invention taken along line


4




a





4




a


of

FIG. 4

;





FIG. 5

is a cross-sectional view of the working end of the second embodiment of the catheter of

FIG. 4

depicting the electrodes in a fully retracted position;





FIG. 6

is a cross-sectional view of an anatomical structure containing the catheter of

FIG. 2

with the electrodes in apposition with the anatomical structure;





FIG. 6



a


is an end view of the anatomical structure containing the catheter taken along line


6




a





6




a


of

FIG. 6

;





FIGS. 7



a


through


7




c


are cross-sectional views of the anatomical structure containing a catheter in accordance with the first embodiment of the invention and depicting the anatomical structure at various stages of ligation;





FIG. 8

is a cross-sectional view of an anatomical structure containing a catheter in accordance with the second embodiment of the invention as depicted in

FIG. 4

;





FIG. 8



a


is an end view of the anatomical structure containing the catheter taken along line


8




a





8




a


of

FIG. 8

; and





FIGS. 9



a


and


9




b


are cross-sectional views of the anatomical structure containing the catheter in accordance with the second embodiment of the invention and depicting the anatomical structure at various stages of ligation;





FIG. 10

is a cross-sectional view of the working end of a third embodiment of a catheter in accordance with the invention depicting the electrodes in a fully extended position;





FIG. 10



a


is an end view of the working end of the third embodiment of the catheter taken along line


10




a





10




a


of

FIG. 10

;





FIG. 11

is a cross-sectional view of the working end of the third embodiment depicting the electrodes in a fully retracted position;





FIG. 12

is a cross-sectional view of an anatomical structure containing the catheter of

FIG. 10

with the electrodes in apposition with the anatomical structure;





FIG. 13

is a cross-sectional view of the anatomical structure containing the catheter of

FIG. 10

where the anatomical structure is being ligated by the application of, energy from the electrodes.





FIG. 14

is a cross-sectional view of an anatomical structure containing the catheter of

FIG. 10

with the electrodes in apposition with the anatomical structure where external compression is being applied to reduce the diameter of the hollow structure before the application of energy from the electrodes to ligate the structure.











DETAILED DESCRIPTION OF THE EMBODIMENTS




Turning now to the drawings with more particularity wherein like reference numerals indicate like or corresponding elements among the figures, shown in

FIG. 1

is a catheter


10


for applying energy to an anatomical structure such as a vein. The catheter


10


includes an outer sheath


12


having a distal orifice


14


at its working end


15


. The connector end


17


of the outer sheath


12


is attached to a handle


16


that includes an electrical connector


18


for interfacing with a power source


22


, typically an RF generator, and a microprocessor controller


23


. The power source


22


and microprocessor


23


are usually contained in one unit. The controller


23


controls the power source


22


in response to external commands and data from a sensor, such as a thermocouple, located at an intraluminal venous treatment site. In another embodiment, the user can select a constant power output so that automated temperature control is not present and the user can manually adjust the power output in view of the temperature on a display readout. The catheter


10


includes an expandable electrode device


24


(partially shown) that moves in and out of the outer sheath


12


by way of the distal orifice


14


. The electrode device includes a plurality of electrodes which can be expanded by moving the electrodes within the shaft, or by moving the outer shaft relative to the electrodes. Although

FIG. 1

illustrates a plurality of electrodes surrounding a single central electrode, different electrode configurations will be described for the catheter.




Contained within the outer sheath


12


is an inner sheath


28


or inner member. A fluid port


21


communicates with the interior of the outer sheath


12


. The catheter


10


can be periodically flushed out with saline through the port


21


. The flushing fluid can travel between the outer sheath and the inner sheath. The port also allows for the delivery of drug therapies. Flushing out the catheter prevents the buildup of biological fluid, such as blood, within the catheter


10


. The treatment area of the hollow anatomical structure such as a vein can be flushed with a fluid such as saline, or a dielectric fluid, in order to evacuate blood from the treatment area of the vein so as to prevent the formation of coagulum or thrombosis. The use of a dielectric fluid can minimize unintended heating effects away from the treatment area. The dielectric fluid prevents the current of RF energy from flowing away from the vein wall.




In one embodiment, the catheter


10


includes a lumen which begins at the distal tip of the outer sheath


12


and runs substantially along the axis of the outer sheath


12


before terminating at the guide-wire port


20


of the handle


16


. A guide wire can be introduced through the lumen of the catheter


10


for use in guiding the catheter to the desired treatment site. Where the catheter is sized to treat smaller veins, the outer diameter of the catheter may not allow for a fluid flush between the outer sheath


12


and the inner sheath


28


. However, a fluid flush can be introduced through the lumen for the guide wire in such an embodiment.




Referring now to

FIGS. 2

,


2




a,




3


,


4


,


4




a


and


5


, the outer sheath


12


includes a shell


44


and a tip portion


46


. To provide an atraumatic tip for the catheter


10


as it is manipulated through the vein, the tip


46


is preferably tapered inward at its distal end or is “nosecone” shaped. The tip


46


, however, can have other shapes that facilitate tracking of the catheter


10


over a guide wire and through the bends in the venous vascular system. The nosecone-shaped tip


46


can, for example, be fabricated from a polymer having a soft durometer, such as 70 Shore A. The shell


44


comprises a biocompatible material having a low coefficient of friction. In one configuration, the outer sheath


12


is sized to fit within a venous lumen and for example may be between 5 and 9 French, which corresponds to a diameter of between 1.7 mm (0.07 in) and 3.0 mm (1.2 in), or other sizes as appropriate.




The electrode device


24


contains a number of leads, including insulated primary leads


30


and, in some embodiments, a secondary lead


31


. Preferably, the leads are connected to the power source


22


(

FIG. 1

) such that the polarity of the leads may be switched as desired. Alternately, a microprocessor controller can be used to switch the polarity, as well as control other characteristics of the power for the electrode device. Thus the electrode device can operate in either a bipolar or a monopolar configuration. When adjacent primary leads


30


have opposite polarity the electrode device


24


operates as a bipolar electrode device. When the primary leads


30


are commonly charged the electrode device


24


can operate as a monopolar electrode device. When the primary leads


30


are commonly charged, and a secondary lead


31


has an opposite polarity, the electrode device


24


operates as a bipolar electrode device. The embodiment of the invention shown in

FIGS. 2 and 3

depict an electrode device


24


having four primary leads


30


and a secondary lead


31


, while the embodiment of the invention shown in

FIGS. 4 and 5

depict an electrode device


24


having only four primary leads. The invention is not limited to four primary leads


30


; more or fewer leads may be used in either embodiment. The number of leads can be dependent on the size or diameter of the hollow anatomical structure to be treated. The apposed electrodes should be kept within a certain distance of one another. Larger vessels may require more primary leads to ensure proper current density and proper heat distribution.




The insulation on each of the leads


30


,


31


may be removed at the distal end


32


,


33


to expose the conductive wire. In the first configuration as shown in

FIGS. 2

,


2




a,


and


3


, the electrode


34


has a hemispherical shape. In a second configuration, the electrode can have either a generally spherical shape or a spoon shape. As shown in

FIGS. 4

,


4




a


and


5


, the electrodes have a spoon shape which can be combined to form a sphere or other shape so as to minimize its profile when the vein collapses. The electrodes


34


are either integrally formed at the distal end


32


, soldered, or otherwise formed to the distal end of each primary lead


30


. It is to be understood that when the distal end


32


is referred to as acting as an electrode, this is not limited to where the electrode


34


is integrally formed at the distal end


32


. For example, the distal end can apply energy to the surrounding tissue where there is an electrode integrally formed at the distal end, or where an electrode is separately soldered to the distalend, or where there is another energy delivery device located at the distal end. The electrode


34


typically has a diameter greater than the diameter of the primary lead


30


. For example, the primary lead


30


may have a diameter ranging from 0.18 mm (0.007 in.) to 0.28 mm (0.011 in.), while the electrode


34


has a diameter of 0.36 mm (0.014 in.) to 0.51 mm (0.020 in.). The primary leads


30


and the electrodes


34


are preferably made from a biologically-compatible material such as stainless steel. The insulation surrounding the primary leads


30


generally has a thickness of between 0.03 mm (0.001 in.) and 0.06 mm (0.0025 in.), resulting in a combined lead-insulation diameter of between 0.23 mm (0.009 in.) and 0.41 mm (0.016 in.). In an alternate configuration, as shown in

FIGS. 2 and 3

, each primary lead


30


is strip-shaped with a width from 0.76 mm (0.03 in.) to 1.0 mm (0.04 in) and a thickness of approximately 0.13 mm (0.005 in.), while the secondary lead


31


is typically tubular-shaped. It should be noted that these dimensions are provided for illustrative purposes, and not by way of limitation. A hemispherically shaped electrode


34


is formed at the distal end, as for example, by sanding down a sixteenth-inch (1.6 mm) diameter sphere which is soldered to the distal end


32


of the primary lead


30


. The electrodes can also be constructed by stamping the desired shape or configuration from the conductive lead. The electrode is integral with the lead, and the remainder of the lead is insulated. The distal end


33


of the secondary lead


31


preferably includes a generally spherically-shaped electrode


35


.




An alignment device


36


arranges the leads


30


,


31


such that they are mounted to the catheter at only their proximal ends and so that separation is maintained between the leads within, and distal to the alignment device. The leads can form cantilevers when mounted on the alignment device. A preferred configuration of the alignment device


36


includes a plurality of off-center, axially-aligned lumina


38


which are substantially symmetrically positioned relative to the axis of the alignment device


36


. The alignment device


36


is formed, for example, by extruding the plurality of axially-aligned lumina


38


through a solid cylinder composed of a dielectric material, such as polyamide. Each lead


30


passes through an individual off-center lumen


38


and exits out the rear of the alignment device


36


. The alignment device


36


may further include a central lumen


48


that may be aligned with the axis. In some embodiments the central lumen


48


is used for accepting a guide wire or for the delivery or perfusion of medicant and cooling solution to the treatment area during application of RF energy. In other embodiments, the central lumen


48


may be used for the secondary lead


31


. The alignment device


36


may also further include an auxiliary lumen


47


for additional leads, such as the leads of, a thermocouple used as a temperature sensor. The alignment device


36


comprises a dielectric material to prevent or minimize any coupling effect the leads


30


,


31


may have with each other and, if present, the guide wire. The length of the alignment device is, for example, 12.5 mm (0.5 in.) to 19.0 mm (0.75 in.) in one embodiment. However, these dimensions are provided for purposes of illustration and not by way of limitation.




In the embodiment of the invention shown in

FIGS. 2

,


2




a


and


3


, the inner sheath


28


is attached to the alignment device


36


and extends beyond the rear


37


of the alignment device. Preferably, the inner sheath


28


completely surrounds the exterior wall of the alignment device


36


and is mounted to it by adhesive or press fit or in other manner such that it remains in a fixed position relative to the inner sheath. The inner sheath and alignment device can act as an inner member relative to the outer sheath. The inner sheath


28


comprises a biocompatible material with a low coefficient of friction. The inner sheath


28


provides a pathway for the interconnection between the leads


30


,


31


and the electrical connector


18


(FIG.


1


). This interconnection may occur in any of several ways. The leads


30


,


31


themselves may be continuous and run the entire length of the inner sheath


28


. In the alternative (not shown), the positively charged leads


30


,


31


may couple with a common positively charged conductor housed in the inner sheath


28


. Likewise, the negatively charged leads


30


,


31


may couple with a common negative conductor. Preferably, the leads


30


,


31


are connected to a conductor that allows for the polarity of the leads to be switched. The conductor may comprise, for example, a


36


gauge copper lead with a polyurethane coating. The coupling may occur at any point within the inner sheath


28


. To reduce the amount of wire contained in the catheter, it is advantageous to couple the leads


30


,


31


at the point where the leads exit the rear


37


of the alignment device


36


. To add further stability to the electrode device


24


, it is preferred that bonding material


40


surround the leads


30


,


31


at the front end of the alignment device


36


. In this embodiment, the leads


30


,


31


exit through the distal orifice


14


as the outer sheath


12


is retracted backwards over the alignment device


36


. The inwardly tapered tip


46


impedes the retracting movement of the outer sheath


12


to prevent the exposure of the alignment device


36


.





FIG. 3

shows the leads


30


and


31


in the retracted position where all leads are within the nosecone-shaped tip portion


46


and the outer shell


44


. The alignment device


36


has been moved relative to the outer shell


44


. The soft nosecone provides an atraumatic tip for when the catheter is maneuvered through the tortuous venous system. The electrode at the distal end of the secondary lead


31


can be sized to approximately the same size as the opening formed in the nosecone


46


. The nosecone forms a closed atraumatic tip together with the electrode of the secondary lead when the alignment device is retracted into the outer sheath of the catheter. This can present an atraumatic tip even where the nosecone is not constructed from a material having a soft durometer.




Referring now to

FIGS. 4 and 5

, in another embodiment, the alignment device


36


is attached to the outer sheath


12


and thereby remains immobile in relation to it. The inner sheath


28


is movably positioned at the rear of the alignment device


36


and again provides a pathway for the interconnection between the primary leads


30


and the electrical connector


18


(FIG.


1


). In some embodiments the inner sheath


28


contains a guide-wire tube


49


that runs the entire length of the inner sheath. The guide-wire tube


49


is aligned to communicate with the central lumen


48


of the alignment device


36


at one end and with the guide-wire port


20


(

FIG. 1

) at the other end. The primary leads


30


may be continuous and run the entire length of the inner sheath


28


or they may be coupled to common leads as previously described. The primary leads


30


are secured to the front end


27


of the inner sheath


28


, as for example with a potting material


50


, so that the movement of the inner sheath


28


results in a corresponding movement of the primary leads


30


through the lumina


38


of the alignment device


36


. In this embodiment, the primary leads


30


are not secured to the alignment device


36


and in essence are free-floating leads in the axial direction. The primary leads


30


travel through the alignment device


36


and exit through the distal orifice


14


as the front end of the inner sheath


28


is moved toward the rear


37


of the alignment device


36


.




In the above embodiments, the primary leads


30


are formed, e.g., arced or bent, to move away from each other and thereby avoid contact. The “distal portion” of the primary leads


30


is the portion of the lead which extends from the front end of the alignment device


36


when the leads are fully extended through the distal orifice


14


. It is preferred that the distal portions


42


are formed to move radially outward from each other relative to the axis of the alignment device


36


and form a symmetrical arrangement. This is shown in both the embodiments of

FIG. 2



a


and

FIG. 4



a.


The degree of arc or bend in the primary leads


30


may be any that is sufficient to radially expand the leads as they exit the outer sheath


12


through the distal orifice


14


. It is essential that the degree of the arc or bend be sufficient to provide enough force so that the primary leads


30


expand through blood and the electrodes


34


come in apposition with the vein wall. The electrodes are preferably partially embedded in the vein wall to assure full contact. The rounded portion of the electrode is embedded into the vein wall to achieve full surface apposition so that the entire uninsulated surface area of the electrode is in contact with venous tissue for effective current distribution. The surface area of the electrodes in contact with the venous tissue preferably is sufficient to avoid a high current density which may lead to spot heating of the venous tissue. The heating effect is preferably distributed along a circumferential band of the vein. The apposed electrodes should be spaced no more than 4 or 5 millimeters from one another along the circumference of the vein. Thus, the electrode arrangement is related to the size or diameter of the vein being treated. Other properties of the primary leads


30


, such as lead shape and insulation thickness, affect the push force of the lead and the degree of arc or bend must be adjusted to compensate for these factors. For example, in one configuration of the electrode device


24


, a wire having a diameter of between 0.18 mm (0.007 in) and 0.28 mm (0.011 in) with a total insulation thickness of between 0.05 mm (0.002 in) to 0.13 mm (0.005 in) is arced or bent at an acute angle to provide sufficient apposition with the anatomical structure. It is to be understood that these dimensions are provided for illustrative purposes, and not by way of limitation.




Other techniques for expanding the leads outwardly once they have been extended from the working end of the catheter may be possible. For example, the leads may be straight but are mounted in the alignment device at an angle such that they are normally directed outward.




For increased appositional force, it is preferred that the primary leads


30


be strip-shaped, that is rectangular in cross section, with dimensions, for example, of a width from 0.76 mm (0.030 in.) to 1.0 mm (0.039 in) and a thickness of approximately 0.13 mm (0.005 in.). The rectangular cross section provides increased resistance to bending in the width dimension but allows bending more freely in the thickness dimension. This strip-shaped configuration of the primary leads


30


is shown in

FIGS. 2

,


2




a,


and


3


and provides for increased stability in the lateral direction while allowing the necessary bending in the radial direction. In

FIGS. 2

,


2




a,


and


3


, each primary lead comprises a rectangular cross section mounted in relation to the catheter such that the thinner dimension of the rectangular cross section is aligned with the direction of expansion of the lead. The leads are less likely to bend sideways when expanded outward, and a uniform spacing between leads is more assured. Uniform spacing promotes uniform heating around the venous tissue which is in apposition with the electrodes at the distal ends of the leads.




The length of the distal portion of the leads


30


also affects the configuration of the electrode device


24


. The maximum distance between two mutually opposed electrodes


34


; i.e., the effective diameter of the electrode device


24


, is affected by the bend degree and length of the distal portion


42


. The longer the length of the distal portion


42


the greater the diameter of the electrode device


24


. Accordingly, by changing the distal portion


42


length and arc or bend degree, the catheter


10


can be configured for use in differently sized anatomical structures.




Different numbers of leads


30


,


31


can be employed with the catheter. The number of leads


30


,


31


is limited by the diameter of the alignment device


36


and the number of lumina


36


,


38


,


47


that can be extruded through the alignment device. In a bipolar configuration, an even number of primary leads


30


are preferably available to form a number of oppositely charged electrode pairs. The electrodes in appostion with the anatomical structure should be maintained within a certain distance of each other. In a monopolar configuration, any number of commonly charged leads


30


can be present. In the monopolar mode, distribution of RF energy through the anatomical tissue is obtained by creating a return path for current through the tissue by providing a return device at a point external from the tissue, such as a large metal pad.




Now referring again to

FIG. 1

, an actuator


25


controls the extension of the electrode device


24


through the distal orifice


14


. The actuator


25


may take the form of a switch, lever, threaded control knob, or other suitable mechanism, and is preferably one that can provide fine control over the movement of the outer sheath


12


or the inner sheath


28


, as the case may be. In one embodiment of the invention, the actuator


25


(

FIG. 1

) interfaces with the outer sheath


12


(

FIGS. 2

,


2




a


and


3


) to move it back and forth relative to the inner sheath


28


. In another embodiment the actuator


25


(

FIG. 1

) interfaces with the inner sheath


28


(

FIGS. 4

,


4




a


and


5


) to move it back and forth relative to the outer sheath


12


. The relative position between the outer sheath and inner sheath is thus controlled, but other control approaches may be used.




Referring again to

FIGS. 2

,


2




a,




3


,


4


,


4




a


and


5


, the catheter


10


includes a temperature sensor


26


, such as a thermocouple. The temperature sensor


26


is mounted in place on an electrode


34


so that the sensor


26


is nearly or is substantially flush with the exposed surface of the electrode


34


. The sensor


26


is shown in the drawings as protruding from the electrodes for clarity of illustration only. The sensor


26


senses the temperature of the portion of the anatomical tissue that is in apposition with the exposed electrode surface. Monitoring the temperature of the anatomical tissue provides a good indication of when shrinkage of the tissue is ready to begin. A temperature sensor


26


placed on the electrode facing the anatomical tissue provides an indication of when shrinkage occurs (70° C. or higher) and when significant amounts of heat-induced coagulum may begin to form on the electrodes (at 85° C. or higher). Therefore maintaining the temperature above 70 degrees Centigrade produces a therapeutic shrinkage of the anatomical structure. Application of the RF energy from the electrodes


34


is halted or reduced when the monitored temperature reaches or exceeds the specific temperature that was selected by the operator, typically the temperature at which anatomical tissue begins to cauterize. The temperature sensor


26


interfaces with the controller


23


(

FIG. 1

) through a pair of sensor leads


45


which preferably run through the auxiliary lumen


47


and then through the inner sheath


28


. The signals from the temperature sensor


26


are provided to the controller


23


which controls the magnitude of RF energy supplied to the electrodes


34


in accordance with the selected temperature criteria and the monitored temperature. Other techniques such as impedance monitoring, and ultrasonic pulse echoing can be utilized in an automated system which shuts down or regulates the application of RF energy from the electrodes to the venous section when sufficient shrinkage of the vein is detected and to avoid overheating the vein.




Referring now to

FIGS. 6

,


6




a


and


7




a


through


7




c,


in the operation of one embodiment of the catheter


10


, the catheter is inserted into a hollow anatomical structure, such as a vein


52


. The catheter is similar to the embodiment discussed in connection with

FIGS. 2 and 3

. The catheter


10


further includes an external sheath


60


through which a fluid can be delivered to the treatment site. In this embodiment, the fluid port (not shown) communicates with the interior of the external sheath


60


, and fluid is delivered from between the external sheath


60


and the outer sheath


12


. The external sheath


60


surrounds the outer sheath


12


to form a coaxial channel through which fluid may be flushed.




Fluoroscopy, ultrasound, an angioscope imaging technique, or other technique may be used to direct the specific placement of the catheter and confirm the position in the vein. The actuator (not shown) is then operated to shift the outer sheath relative to the inner sheath by either retracting the outer sheath


12


backward or advancing the inner sheath


28


forward to expose the leads


30


,


31


through the distal orifice


14


. As the leads


30


,


31


exit the distal orifice


14


, the primary leads


30


expand radially outward relative to the axis of the alignment device


36


, while the secondary lead


31


remains substantially linear. The primary leads


30


continue to move outward until apposition with the vein wall


54


occurs and the outward movement of the primary leads


30


is impeded. The primary leads


30


contact the vein along a generally circumferential band of the vein wall


54


. This outward movement of the primary leads


30


occurs in a substantially symmetrical fashion. As a result, the primary-lead electrodes


34


are substantially evenly spaced along the circumferential band of the vein wall


54


. The central-lead electrode


35


is suspended within the vein


52


without contacting the vein wall


54


.




When the electrodes


34


are positioned at the treatment site of the vein, the power supply


22


is activated to provide suitable RF energy, preferably at a selected frequency from a range of 250 kHz to 350 MHZ. One suitable frequency is 510 kHz. One criterion used in selecting the frequency of the energy to be applied is the control desired over the spread, including the depth, of the thermal effect in the venous tissue. Another criterion is compatibility with filter circuits for eliminating RF noise from thermocouple signals.




In bipolar operation, the primary leads


30


are initially charged such that adjacent leads are oppositely charged while the secondary lead is electrically neutral. These multiple pairs of oppositely charged leads


30


form active electrode pairs to produce an RF field between them. Thus, discrete RF fields are set up along the circumferential band of the vein wall


54


. These discrete fields form a symmetrical RF field pattern along the entire circumferential band of the vein wall


54


, as adjacent electrodes


34


of opposite polarity produce RF fields between each other. A uniform temperature distribution can be achieved along the vein wall being treated.




The RF energy is converted within the adjacent venous tissue into heat, and this thermal effect causes the venous tissue to shrink, reducing the diameter of the vein. A uniform temperature distribution along the vein wall being treated avoids the formation of hot spots in the treatment area while promoting controlled uniform reduction in vein diameter. The thermal effect produces structural transfiguration of the collagen fibrils in the vein. The collagen fibrils shorten and thicken in cross-section in response to the heat from the thermal effect. As shown in

FIG. 7



a,


the energy causes the vein wall


54


to collapse around the primary-lead electrodes


34


. The wall


54


continues to collapse until further collapse is impeded by the electrodes


34


. The electrodes are pressed farther and farther together by the shrinking vein wall


54


until they touch and at that point, further collapse or ligation of the wall


54


is impeded. Upon collapse of the vein wall


54


around the primary-lead electrodes


34


, the polarity of the primary-lead electrodes is switched so that all primary-lead electrodes are commonly charged. The switching of polarity for the leads need not be instantaneous. The application of RF energy can be ceased, the polarity switched, and then RF energy is applied again at the switched polarity. The secondary-lead electrode


35


is then charged so that its polarity is opposite that of the primary-lead electrodes


34


. The RF field is set up between the primary-lead electrodes


34


and the secondary-lead electrode


35


.




The catheter


10


is then pulled back while energy is applied to the electrode device. As shown in

FIG. 7



b,


while the catheter


10


is being pulled back, the primary-lead electrodes


34


remain in apposition with the vein wall


54


while the secondary-lead electrode


35


comes in contact with the portion of the vein wall previously collapsed by the primary-lead electrodes


34


. Accordingly, RF energy passes through the vein wall


54


between the primary-lead electrodes


34


and the secondary-lead electrode


35


and the vein wall continues to collapse around the secondary-lead electrode


35


as the catheter is being retracted. As shown in

FIG. 7



c,


ligation in accordance with this method results in an occlusion along a length of the vein


52


. A lengthy occlusion, as opposed to an acute occlusion, is stronger and less susceptible to recanalization.




A similar result is achieved when the catheter


10


having both primary and secondary leads is operated in a monopolar manner. In a monopolar operation, the secondary-lead electrode


35


remains neutral, while the primary leads


30


are commonly charged and act in conjunction with an independent electrical device, such as a large low-impedance return pad (not shown) placed in external contact with the body, to form a series of discrete RF fields. These RF fields are substantially evenly spaced around the circumference of the vein and travel along the axial length of the vein wall causing the vein wall to collapse around the primary-lead electrodes. Upon collapse of the vein wall, the secondary-lead electrode is charged to have the same polarity as that of the primary-lead electrodes. The electrode device is retracted and the vein wall collapses as described in the bipolar operation.




In either bipolar or monopolar operation the application of RF energy is substantially symmetrically distributed through the vein wall, regardless of the diameter of the vein


52


. This symmetrical distribution of RF energy increases the predictability and uniformity of the shrinkage and the strength of the occlusion. Furthermore, the uniform distribution of energy allows for the application of RF energy for a short duration and thereby reduces or avoids the formation of heat-induced coagulum on the electrodes


34


. The leads, including the non-convex outer portion of the electrode, are insulated to further prevent heating of the surrounding blood.




Fluid can be delivered before and during RF heating of the vein being treated through a coaxial channel formed between the external sheath


60


and the outer sheath


12


. It is to be understood that another lumen can be formed in the catheter to deliver fluid to the treatment site. The delivered fluid displaces or exsanguinates blood from the vein so as to avoid heating and coagulation of blood. Fluid can continue to be delivered during RF treatment to prevent blood from circulating back to the treatment site. The delivery of a dielectric fluid increases the surrounding impedance so that RF energy is directed into the tissue of the vein wall.




Referring now to

FIGS. 8

,


8




a,




9




a


and


9




b,


in the operation of an alternate embodiment of the catheter


10


that may be used with a guide wire


53


. As in the previous embodiment, the catheter


10


is inserted into a hollow anatomical structure, such as a vein


52


. The guide wire


53


is advanced past the point where energy application is desired. The catheter


10


is then inserted over the guide wire


53


by way of the central lumen


48


and the guide wire tube


49


(

FIG. 4

) and is advanced over the guide wire through the vein to the desired point. The guide wire


53


is typically pulled back or removed before RF energy is applied to the electrode device


24


.




The actuator


25


(

FIG. 1

) is then manipulated to either retract the outer sheath


12


backward, or advance the inner sheath


28


forward to expose the leads


30


through the distal orifice


14


. The leads


30


exit the distal orifice


14


and expand radially outward relative to the axis of the alignment device


36


. The leads


30


continue to move outward until apposition with the vein wall


54


occurs. The leads


30


contact the vein along a generally circumferential band of the vein wall


54


. This outward movement of the leads occurs in a substantially symmetrical fashion. As a result, the electrodes


34


are substantially evenly spaced along the circumferential band of the vein wall


54


. Alternately, the electrodes can be spaced apart in a staggered fashion such that the electrodes do not lie along the same plane. For example, adjacent electrodes can extend different lengths from the catheter so that a smaller cross-sectional profile is achieved when the electrodes are collapsed toward one another.




When the electrodes


34


are positioned at the treatment site of the vein, the power supply


22


is activated to provide suitable RF energy to the electrodes


34


so that the catheter


10


operates in either a bipolar or monopolar manner as previously described. As shown in

FIGS. 9



a


and


9




b,


the energy causes the vein wall


54


to collapse around the electrodes


34


causing the leads to substantially straighten and the electrodes to cluster around each other. The wall


54


continues to collapse until further collapse is impeded by the electrodes


34


(

FIG. 9



b


). At this point the application of energy may cease. The electrodes can be configured to form a shape with a reduced profile when collapsed together. The electrodes can also be configured and insulated to continue applying RF energy after forming a reduced profile shape by the collapse of the vein wall. The catheter


10


can be pulled back to ligate the adjacent venous segment. If a temperature sensor


26


is included, the application of energy may cease prior to complete collapse if the temperature of the venous tissue rises above an acceptable level as defined by the controller


23


.




Where the catheter includes a fluid delivery lumen (not shown), fluid can be delivered before and during RF heating of the vein being treated. The fluid can displace blood from the treatment area in the vein to avoid the coagulation of blood. The fluid can be a dielectric medium. The fluid can include an anticoagulant such as heparin which can chemically discourage the coagulation of blood at the treatment site.




After completing the procedure for a selected venous section, the actuator mechanism causes the primary leads to return to the interior of the outer sheath


12


. Either the outer sheath or the inner sheath is moved to change the position of the two elements relative to one another. Once the leads


30


are within the outer sheath


12


, the catheter


10


may be moved to another venous section where the ligation process is repeated. Upon treatment of all venous sites, the catheter


10


is removed from the vasculature. The access point of the vein is then sutured closed, or local pressure is applied until bleeding is controlled.




Another embodiment of the catheter is illustrated in FIG.


10


. The inner member or sheath


28


is contained within the outer sheath


12


. The inner sheath is preferably constructed from a flexible polymer such as polyimide, polyethylene, or nylon, and can travel the entire length of the catheter. The majority of the catheter should be flexible so as to navigate the tortuous paths of the venous system. A hypotube having a flared distal end


33


and a circular cross-sectional shape is attached over the distal end of the inner sheath


28


. The hypotube is preferably no more than about two to three centimeters in length. The hypotube acts as part of the conductive secondary lead


31


. An uninsulated conductive electrode sphere


35


is slipped over the hypotube. The flared distal end of the hypotube prevents the electrode sphere from moving beyond the distal end of the hypotube. The sphere is permanently affixed to the hypotube, such as by soldering the sphere both front and back on the hypotube. The majority or the entire surface of the spherical electrode


35


remains uninsulated. The remainder of the hypotube is preferably insulated so that the sphere-shaped distal end can act as the electrode. For example, the hypotube can be covered with an insulating material such as a coating of parylene. The interior lumen of the hypotube is lined by the inner sheath


28


which is attached to the flaired distal end of the hypotube by adhesive such as epoxy.




Surrounding the secondary lead


31


and sphere-shaped electrode


35


are a plurality of primary leads


30


which preferably have a flat rectangular strip shape and can act as arms. As illustrated in

FIG. 11

, the plurality of primary leads are preferably connected to common conductive rings


62


. This configuration maintains the position of the plurality of primary leads, while reducing the number of internal electrical connections. The rings


62


are attached to the inner sheath


28


. The position of the rings and the primary leads relative to the outer sheath follows that of the inner sheath. As earlier described, the hypotube of the secondary lead


31


is also attached to the inner sheath


28


. Two separate conductive rings can be used so that the polarity of different primary leads can be controlled separately. For example, adjacent primary leads can be connected to one of the two separate conductive rings so that the adjacent leads can be switched to have either opposite polarities or the same polarity. The rings are preferable spaced closely together, but remain electrically isolated from one another along the inner sheath. Both the rings and the hypotube are coupled with the inner sheath, and the primary leads


30


that are connected to the rings move together with and secondary lead while remaining electrically isolated from one another. Epoxy or another suitable adhesive can be used to attach the rings to the inner sheath. The primary leads from the respective rings each alternate with each other along the circumference of the inner sheath. The insulation along the underside of the leads prevents an electrical short between the rings.




The ring and primary leads are attached together to act as cantilevers where the ring forms the base and the rectangular primary leads operate as the cantilever arms. The leads


30


are connected to the ring and are formed to have an arc or bend such that the leads act as arms which tend to spring outwardly away from the catheter and toward the surrounding venous tissue. Insulation along the underside of the leads and the rings prevents unintended electrical coupling between the leads and the opposing rings. Alternately, the leads are formed straight and connected to the ring at an angle, such that the leads tend to expand or spring radially outward from the ring. The angle at which the leads are attached to the ring should be sufficient to force the primary distal ends and electrodes


34


through blood and into apposition with the vein wall. Other properties of the primary leads


30


, such as lead shape and insulation thickness, affect the push force of the lead and the degree of arc or bend must be adjusted to compensate for these factors. The rectangular cross section of the leads


30


can provide increased stability in the lateral direction while allowing the necessary bending in the radial direction. The leads


30


are less likely to bend sideways when expanded outward, and a uniform spacing between leads is more assured. Uniform spacing between the leads


30


and the distal ends promotes uniform heating around the vein by the electrodes


34


.




The distal ends of the primary leads


30


are uninsulated to act as electrodes


34


having a spoon or hemispherical shape. The leads can be stamped to produce an integral shaped electrode at the distal end of the lead. The uninsulated outer portion of the distal end electrode


34


which is to come into apposition with the wall of the anatomical structure is preferably rounded and convex. The flattened or non-convex inner portion of the distal end is insulated to minimize any unintended thermal effect, such as on the surrounding blood in a vein. The distal end electrodes


34


are configured such that when the distal ends are forced toward the inner sheath


12


, as shown in

FIG. 10



a,


the distal ends combine to form a substantially spherical shape with a profile smaller than the profile for the spherical electrode


35


at the secondary distal end.




The outer sheath


12


can slide over and surround the primary and secondary leads


30


,


31


. The outer sheath


12


includes an orifice which is dimensioned to have approximately the same size as the spherical electrode


35


at the secondary distal end which functions as an electrode. A close or snug fit between the electrode


35


at the secondary distal end and the orifice of the outer sheath


12


is achieved. This configuration provides an atruamatic tip for the catheter. The electrode


35


secondary distal end is preferably slightly larger than the orifice. The inner diameter of the outer sheath


12


is approximately the same as the reduced profile of the combined primary distal end electrodes


34


. The diameter of the reduced profile of the combined primary distal end electrodes


34


is preferably less than the inner diameter of the outer sheath.




A fluid port (not shown) can communicate with the interior of the outer sheath


12


so that fluid can be flushed between the outer sheath


12


and the inner sheath


28


. Alternately, a fluid port can communicate with a central lumen


48


in the hypotube which can also accept a guidewire. As previously stated, the catheter


10


can be periodically flushed with saline which can prevent the buildup of biological fluid, such as blood, within the catheter


10


. A guide wire can be introduced through the lumen


48


for use in guiding the catheter to the desired treatment site. As previously described, a fluid can be flushed or delivered though the lumen as well. If a central lumen is not desired, the lumen of the hypotube can be filled with solder.




Preferably, the primary leads


30


and the connecting rings are connected to a power source


22


such that the polarity of the leads may be switched as desired. This allows for the electrode device


24


to operate in either a bipolar or a monopolar configuration. When adjacent primary leads


30


have opposite polarity, a bipolar electrode operation is available. When the primary leads


30


are commonly charged a monopolar electrode operation is available in combination with a large return electrode pad placed in contact with the patient. When the primary leads


30


are commonly charged, and a secondary lead


31


has an opposite polarity, a bipolar electrode operation is available. More or fewer leads may be used. The number of leads can be dependent on the size or diameter of the hollow anatomical structure to be treated.




Although not shown, it is to be understood that the catheter


10


can include a temperature sensor, such as a thermocouple, mounted in place on the distal end or electrode


34


so that the sensor is substantially flush with the exposed surface of the electrode


34


. The sensor senses the temperature of the portion of the anatomical tissue that is in apposition with the exposed electrode surface. Application of the RF energy from the electrodes


34


is halted or reduced when the monitored temperature reaches or exceeds the specific temperature that was selected by the operator, such as the temperature at which anatomical tissue begins to cauterize. Other techniques such as impedance monitoring, and ultrasonic pulse echoing can be utilized in an automated system which shuts down or regulates the application of RF energy from the electrodes to the venous section when sufficient shrinkage of the vein is detected and to avoid overheating the vein.




Referring now to

FIGS. 12 through 14

, in the operation of one embodiment of the catheter


10


, the catheter is inserted into a hollow anatomical structure, such as a vein. Fluoroscopy, ultrasound, an angioscope imaging technique, or another technique may be used to direct and confirm the specific placement of the catheter in the vein. The actuator is then operated to retract the outer sheath


12


to expose the leads


30


,


31


. As the outer sheath no longer restrains the leads, the primary leads


30


move outward relative to the axis defined by the outer sheath, while the secondary lead


31


remains substantially linear along the axis defamed by the outer sheath. The primary leads


30


continue to move outward until the distal end electrode


34


of the primary leads are placed in apposition with the vein wall


54


occurs and the outward movement of the primary leads


30


is impeded. The primary leads


30


contact the vein along a generally circumferential area of the vein wall


54


. This outward movement of the primary leads


30


occurs in a substantially symmetrical fashion so that the primary distal end electrodes


34


are substantially evenly spaced. The central-lead electrode


35


is suspended within the vein without contacting the vein wall


54


.




When the electrodes


34


are positioned at the treatment site of the vein, the power supply


22


is activated to provide suitable RF energy. In a bipolar operation, the primary leads


30


are initially charged such that adjacent leads are oppositely charged while the secondary lead is electrically neutral. These multiple pairs of oppositely charged leads


30


form active electrode pairs to produce an RF field between them, and form a symmetrical RF field pattern along a circumferential band of the vein wall to achieve a uniform temperature distribution along the vein wall being treated.




The RF energy produces a thermal effect which causes the venous tissue to shrink, reducing the diameter of the vein. As shown in

FIG. 13

, the energy causes the vein wall


54


to collapse until further collapse is impeded by the electrodes


34


. The electrodes are pressed closer together by the shrinking vein wall. The electrodes


34


are pressed together to assume a reduced profile shape which is sufficiently small so that the vein is effectively ligated. Upon collapse of the vein wall


54


around the primarylead electrodes


34


, the polarity of the primary-lead electrodes is switched so that all of the primary-lead electrodes are commonly charged. The secondary-lead electrode


35


is then charged so that its polarity is opposite that of the primary-lead electrodes


34


. Where the primary electrodes


34


and the secondary electrode


35


are spaced sufficiently close together, when the vein wall collapses around the primary lead electrodes, the electrode at the distal end of the secondary lead can also come into contact with the a portion of the vein wall so that an RF field is created between the primary electrodes


34


and the secondary electrode


35


.




The catheter


10


is pulled back to ensure apposition between the electrodes at the distal ends of the leads and the vein wall. When the catheter


10


is being pulled back, the primary-lead electrodes


34


remain in apposition with the vein wall


54


while the secondary-lead electrode


35


comes in contact with the portion of the vein wall previously collapsed by the primary-lead electrodes


34


. RF energy passes through the venous tissue between the primary-lead electrodes


34


and the secondary-lead electrode


35


. Ligation as the catheter is being retracted produces a lengthy occlusion which is stronger and less susceptible to recanalization than an acute point occlusion.




In a monopolar operation, the secondary-lead electrode


35


remains neutral, while the primary leads


30


are commonly charged and act in conjunction with an independent electrical device, such as a large low-impedance return pad (not shown) placed in external contact with the body, to form RF fields substantially evenly spaced around the circumference of the vein. The thermal effect produced by those RF fields along the axial length of the vein wall causes the vein wall to collapse around the primary-lead electrodes. Upon collapse of the vein wall, the secondary-lead electrode is charged to have the same polarity as that of the primary-lead electrodes. The electrode device is retracted as described in the bipolar operation.




In either bipolar or monopolar operation the application of RF energy is substantially symmetrically distributed through the vein wall. As previously described, the electrodes should be spaced no more than 4 or 5 millimeters apart along the circumference of the vein, which defines the target vein diameter for a designed electrode catheter. Where the electrodes are substantially evenly spaced in a substantially symmetrical arrangement, and the spacing between the electrodes is maintained, a symmetrical distribution of RF energy increases the predictability and uniformity of the shrinkage and the strength of the occlusion.




As shown in

FIG. 14

, after the electrodes


34


come into apposition with the vein wall (FIG.


12


), and before the energy is applied to ligate the vein (FIG.


13


), an external tourniquet, such as an elastic compressive wrap or an inflatable bladder with a window transparent to ultrasound, is used to compress the anatomy, such as a leg, surrounding the structure to reduce the diameter of the vein. Although the compressive force being applied by the tourniquet may effectively ligate the vein, or otherwise occlude the vein by flattening the vein, for certain veins, this compressive force will not fully occlude the vein. A fixed diameter electrode catheter in this instance would not be effective. The electrodes


34


which are expanded outward by the formed leads


30


can accommodate this situation.




The reduction in vein diameter assists in pre-shaping the vein to prepare the vein to be molded to a ligated state. The use of an external tourniquet also exsanguinates the vein and blood is forced away from the treatment site. Coagulation of blood during treatment can be avoided by this procedure. Energy is applied from the electrodes to the exsanguinated vein, and the vein is molded to a sufficiently reduced diameter to achieve ligation. The external tourniquet can remain in place to facilitate healing.




The catheter can be pulled back during the application of RF energy to ligate an extensive section of a vein. In doing so, instead of a single point where the diameter of the vein has been reduced, an extensive section of the vein has been painted by the RF energy from the catheter. Retracting the catheter in this manner produces a lengthy occlusion which is less susceptible to recanalization. The combined use of the primary and secondary electrodes can effectively produce a reduced diameter along an extensive length of the vein. The catheter can be moved while the tourniquet is compressing the vein, of after the tourniquet is removed.




Where the catheter includes a fluid delivery lumen, fluid can be delivered to the vein before RF energy is applied to the vein. The delivered fluid displaces blood from the treatment site to ensure that blood is not present at the treatment site, even after the tourniquet compresses the vein.




Where the tourniquet is an inflatable bladder with a window transparent to ultrasound, an ultrasound transducer is used to monitor the flattening or reduction of the vein diameter from the compressive force being applied by the inflating bladder. The window can be formed from polyurethane, or a stand-off of gel contained between a polyurethane pouch. A gel can be applied to the window to facilitate ultrasound imaging of the vein by the transducer. Ultrasound visualization through the window allows the operator to locate the desired venous treatment area, and to determine when the vein has been effectively ligated or occluded. Ultrasound visualization assists in monitoring any pre-shaping of the vein in preparation of being molded into a ligated state by the thermal effect produced by the RF energy from the electrodes.




After completing the procedure for a selected venous section, the actuator causes the leads


30


to return to the interior of the outer sheath


12


. Once the leads


30


are within the outer sheath


12


, the catheter


10


may be moved to another venous section where the ligation process is repeated.




The description of the component parts discussed above are for a catheter to be used in a vein ranging in size from 2 mm (0.08 in) to 10 mm (0.4 in) in diameter. It is to be understood that these dimensions do not limit the scope of the invention and are merely exemplary in nature. The dimensions of the component parts may be changed to configure a catheter


10


that may used in various-sized veins or other anatomical structures.




Although described above as positively charged, negatively charged, or as a positive conductor or negative conductor, these terms are used for purposes of illustration only. These terms are generally meant to refer to different electrode potentials and are not meant to indicate that any particular voltage is positive or negative. Furthermore, other types of energy such as light energy from fiber optics can be used to create a thermal effect in the hollow anatomical structure undergoing treatment.




While several particular forms of the invention have been illustrated and described, it will be apparent that various modifications can be made without departing from the spirit and scope of the invention. Accordingly, it is not intended that the invention be limited, except as by the appended claims.



Claims
  • 1. A method of applying energy from a power source to a hollow anatomical structure from within the structure, the hollow anatomical structure having an inner wall, the method comprising the steps of:introducing into the hollow anatomical structure a catheter having a working end, and a plurality of leads disposed at the working end, each lead having a distal end, each lead being connected to the power source; expanding the leads outwardly from the catheter, wherein the distal ends of the leads move away from each other and into non-penetrating contact with the inner wall of the hollow anatomical structure; applying energy to the hollow anatomical structure from the distal end of the leads until the hollow anatomical structure assumes a significantly reduced diameter for effective ligation.
  • 2. The method of claim 1 wherein the step of expanding the leads comprises the step of expanding the leads such that the distal ends of the leads are spaced such that the distal ends of the leads are no more than 5 millimeters apart along the hollow anatomical structure.
  • 3. The method of claim 1 further comprising the step of extending the leads through an orifice formed in the working end of the catheter, wherein the distance between two mutually opposed distal ends is greater than the diameter of the working end in the step of expanding the distal ends when the leads are extended through the orifice.
  • 4. The method of claim 3 wherein separation between the leads is maintained with an alignment device positioned inside an outer sheath of the catheter; and further comprising the step of moving the outer sheath in relation to the alignment device to extend the leads out the orifice.
  • 5. The method of claim 3 wherein separation between the leads is maintained with an alignment device positioned inside an outer sheath of the catheter, and the leads are attached to an inner sheath; and further comprising the step of moving the outer sheath in relation to the inner sheath to extend the leads through the orifice.
  • 6. The method of claim 3 further comprising a secondary lead located at the working end, the secondary lead having a distal end and having a length exceeding that of the plurality of leads; and wherein the step of extending the plurality of leads further includes the step of extending the secondary lead through the distal orifice.
  • 7. The method of claim 6 wherein the step of applying energy to the anatomical structure comprises the steps of:controlling the power source so that adjacent leads are of opposite polarity while maintaining the secondary lead so that it is electrically neutral; switching the polarity of the leads so that they are all of the same polarity upon collapse of the anatomical structure around the leads; and controlling the power source so that the secondary lead is of opposite polarity relative to the leads upon switching the polarity of the leads so that they are of the same polarity.
  • 8. The method of claim 1 further comprising the step of moving the catheter in the anatomical structure while continuing to apply energy to the anatomical structure.
  • 9. The method of claim 8 wherein the step of moving the catheter comprises the step of moving the catheter in the hollow anatomical structure along a portion of the structure while continuing to apply energy to the anatomical structure during the movement of the catheter as the anatomical structure collapses around the catheter to form a lengthy effective occlusion.
  • 10. The method of claim 1 further comprising the step of exsanguinating the hollow anatomical structure before the step of applying energy.
  • 11. The method of claim 10 wherein the step of exsanguinating the hollow anatomical structure includes the step of delivering fluid to displace blood from the anatomical structure.
  • 12. The method of claim 10 wherein the step of exsanguinating the hollow anatomical structure includes the step of compressing the hollow anatomical structure.
  • 13. The method of claim 1 wherein the step of introducing a catcher having a plurality of leads into the hollow anatomical structure comprises the step of introducing a plurality of leads that are mounted to the working end in cantilever arrangement.
  • 14. The method of claim 1 wherein the step of expanding the leads away from each other comprises the step of forming a bend in each lead, the bend formed in the direction away from the other leads such that each lead tends to move outward away from the other leads.
  • 15. The method of claim 1 further comprising the steps of:moving the catheter along the hollow anatomical structure while the leads remain in apposition with the inner wall of the hollow anatomical structure; and the step of applying energy occurs continually during the step of moving the catheter.
  • 16. The method of claim 1 further comprising the steps of:sensing the temperature at the distal end of a lead; controlling the application of power to the leads in response to the temperature sensed at the distal end.
  • 17. The method of claim 1 wherein the step of applying energy to the anatomical structure comprises the step of controlling the power source so that all leads are of the same potential.
  • 18. The method of claim 1 further comprising the step of flushing the hollow anatomical structure with fluid before the step of applying energy.
  • 19. The method of claim 18 wherein the step of flushing comprises the step of delivering flushing fluid to the hollow anatomical structure from the working end of the catheter.
  • 20. The method of claim 19 wherein the step of delivering flushing fluid comprises the step of conducting the flushing fluid from a proximal end of the catheter to the working end through a lumen adapted to receive a guide wire.
  • 21. The method of claim 19 wherein the step of delivering flushing fluid comprises the step of conducting the flushing fluid from a proximal end of the catheter to the working end through a lumen located between an outer sheath and an inner sheath.
  • 22. The method of claim 19 wherein the step of flushing fluid comprises the step of delivering saline to the hollow anatomical structure.
  • 23. The method of claim 19 wherein the step of flushing fluid comprises the step of delivering dielectric fluid to the hollow anatomical structure, the dielectric fluid selected to direct energy into the tissue of the hollow anatomical structure.
  • 24. The method of claim 19 wherein the step of flushing fluid comprises the step of delivering heparin to the hollow anatomical structure.
  • 25. The method of claim 1 further comprising the step of compressing the hollow anatomical structure before the step of applying energy.
  • 26. The method of claim 1 further comprising the step of compressing the hollow anatomical structure after the step of expanding the leads.
  • 27. The method of claim 1 further comprising the steps of:compressing the hollow anatomical structure with a tourniquet; and monitoring the hollow anatomical structure through an ultrasound window formed in the tourniquet.
  • 28. The method of claim 1 further comprising the step of compressing the hollow anatomical structure so as to reduce the diameter of the hollow anatomical structure to a desired diameter for ligation, wherein the expanded leads are moved toward one another by the compressed hollow anatomical structure.
  • 29. A method of ligating a vein by applying energy to the vein from within the vein from an energy source, the vein having an inner wall, comprising the steps of:introducing into the vein a catheter having a working end and a plurality of energy delivery devices disposed at the working end, each energy delivery device being connected to the energy source; bringing the energy delivery devices into non-penetrating apposition with the inner wall of the vein; moving the catheter along the vein while the energy delivery devices remain in non-penetrating apposition with the inner wall of the vein; and applying energy to the inner wall of the vein with the energy delivery devices during movement of the catheter such that the vein durably assumes a significantly reduced diameter for effective ligation.
  • 30. The method of ligating a vein of claim 29 wherein the step of applying energy to the inner wall of the vein comprises the step of continually applying electrical energy to the inner wall of the vein from the energy delivery devices during movement of the catheter.
  • 31. The method of ligating a vein of claim 29 further comprising the step of expanding the energy delivery devices from the catheter into apposition with the inner vein wall.
  • 32. The method of ligating a vein of claim 29 wherein the step of moving the catheter further includes the step of retracting the catheter.
  • 33. A method of ligating a hollow anatomical structure by applying energy to the hollow anatomical structure from within the hollow anatomical structure with an energy source, the hollow anatomical structure having an inner wall, the method comprising the steps of:introducing into the hollow anatomical structure a catheter having a working end and a plurality of energy delivery devices disposed at the working end, each energy delivery device having a distal end, each energy delivery device being connected to the energy source; bringing the energy delivery devices into non-penetrating apposition with the inner wall of the hollow anatomical structure; compressing the hollow anatomical structure to stop blood flow and remove blood from the hollow anatomical structure at a site where energy is to be delivered; delivering fluid to the hollow anatomical structure by the catheter to prevent coagulum; moving the catheter along the hollow anatomical structure while the energy delivery devices remain in non-penetrating apposition with the inner wall of the hollow anatomical structure; sensing the temperature at an energy delivery device controlling the application of energy to the energy delivery device in accordance with the temperature sensed; and continually applying energy to the inner wall of the hollow anatomical structure with the energy delivery devices during movement of the catheter such that the hollow anatomical structure wall collapses around the catheter as it is being moved to create a lengthy occlusion.
  • 34. A method of ligating a vein by applying energy to the vein from within the vein with an energy source, the vein having an inner wall, the method comprising the steps of:introducing into the vein a catheter having a working end and a plurality of energy delivery devices disposed at the working end, each energy delivery device having a distal end, each energy delivery device being connected to the energy source; bringing the energy delivery devices into non-penetrating apposition with the inner wall of the vein; compressing the vein to stop blood flow and remove blood from the vein at a site where energy is to be delivered; delivering fluid to the vein by the catheter to prevent coagulum; moving the catheter along the vein while the energy delivery devices remain in non-penetrating apposition with the inner wall of the vein; sensing the temperature at an energy delivery device controlling the application of energy to the energy delivery device in accordance with the temperature sensed; and continually applying energy to the inner wall of the vein with the energy delivery devices during movement of the catheter such that the vein wall collapses around the catheter as it is being moved to create a lengthy occlusion.
  • 35. A method of applying energy to a hollow anatomical structure containing an ambient fluid, the method comprising the steps of:introducing into the hollow anatomical structure a catheter having a working end, and a plurality of leads disposed at the working end, each lead having a distal end; expanding the leads outwardly from the working end of the catheter at a treatment area within the hollow anatomical structure, wherein the distal ends of the leads move into contact with the hollow anatomical structure; displacing the ambient fluid from the treatment area within the hollow anatomical structure; applying energy to the hollow anatomical structure from the distal end of the leads until the hollow anatomical structure durably assumes a significantly reduced diameter for effective ligation.
  • 36. The method of claim 35 wherein the step of exsanguinating the hollow anatomical structure occurs before the step of applying energy.
  • 37. The method of claim 35 wherein the step of exsanguinating the hollow anatomical structure includes the step of compressing the hollow anatomical structure.
  • 38. The method of claim 35 wherein the step of exsanguinating the hollow anatomical structure includes the step of delivering fluid to displace blood from the hollow anatomical structure.
  • 39. The method of claim 38 wherein the step of delivering fluid further includes the step of conducting the fluid from a proximal end of the catheter to the working end through a lumen adapted to receive a guide wire.
  • 40. The method of claim 38 wherein the step of delivering fluid further includes the step of conducting the fluid from a proximal end of the catheter to the working end through a lumen located between an outer sheath and an inner sheath.
  • 41. The method of claim 38 wherein the step of delivering fluid further includes the step of delivering dielectric fluid to the hollow anatomical structure.
  • 42. A method of applying energy to a hollow anatomical structure, the method comprising the steps of:introducing into the hollow anatomical structure a catheter having a working end, and a plurality of arms disposed at the working end, each arm having an energy application portion; deploying the arms, wherein the energy application portions contact the hollow anatomical structure; compressing the hollow anatomical structure; applying energy to the hollow anatomical structure from the energy application portions until the hollow anatomical structure durably assumes a significantly reduced diameter for effective ligation.
  • 43. The method of claim 42 wherein the step of compressing the hollow anatomical structure occurs before the step of applying energy.
  • 44. The method of claim 42 further comprising the step of delivering fluid to displace blood from the hollow anatomical structure.
  • 45. The method of claim 44 wherein the step of delivering fluid further includes the step of delivering dielectric fluid to the hollow anatomical structure.
  • 46. The method of claim 42 wherein the step of compressing the hollow anatomical structure occurs after the step of expanding the leads.
  • 47. The method of claim 42 wherein the step of compressing the hollow anatomical structure further includes the step of compressing the hollow anatomical structure with a tourniquet; and monitoring the hollow anatomical structure through an ultrasound window formed in the tourniquet.
  • 48. The method of claim 42 wherein the expanded leads are moved toward one another by the compressed hollow anatomical structure during the step of compressing the hollow anatomical structure.
Parent Case Info

This is a divisional application of Ser. No. 08/927,251 Sep. 11, 1997.

US Referenced Citations (64)
Number Name Date Kind
373339 Hamilton Nov 1887
659409 Mosher Oct 1900
833759 Sourwine Oct 1906
985865 Turner, Jr. Mar 1911
3230957 Seifert Jan 1966
3301258 Werner et al. Jan 1967
3557794 Van Patten Jan 1971
3920021 Hiltebrandt Nov 1975
4016886 Doss et al. Apr 1977
4043338 Homm et al. Aug 1977
4119102 LeVeen Oct 1978
4154246 LeVeen May 1979
4312364 Convert et al. Jan 1982
4346715 Gammell Aug 1982
4522205 Taylor et al. Jun 1985
4643186 Rosen et al. Feb 1987
4660571 Hess et al. Apr 1987
4664120 Hess May 1987
4699147 Chilson et al. Oct 1987
4709698 Johnston et al. Dec 1987
4765331 Petruzzi et al. Aug 1988
4776349 Nashef et al. Oct 1988
4807620 Strul et al. Feb 1989
4823812 Eshel et al. Apr 1989
4945912 Langberg Aug 1990
4966597 Cosman Oct 1990
4976711 Parins et al. Dec 1990
4979948 Geddes et al. Dec 1990
5010894 Edhag Apr 1991
5057107 Parins et al. Oct 1991
5078717 Parins et al. Jan 1992
5117828 Metzger et al. Jun 1992
5122137 Lennox Jun 1992
5155602 Nichols Oct 1992
5156151 Imran Oct 1992
5215103 Desai Jun 1993
5255678 Desluariers et al. Oct 1993
5263493 Avitall Nov 1993
5275610 Eberbach Jan 1994
5282845 Bush Feb 1994
5293869 Edwards et al. Mar 1994
5383917 Desai et al. Jan 1995
5397339 Desai Mar 1995
5405322 Lennox et al. Apr 1995
5409000 Imran Apr 1995
5411025 Webster, Jr. May 1995
5423815 Fugo Jun 1995
5437664 Cohen et al. Aug 1995
5449381 Imran Sep 1995
5458596 Lax et al. Oct 1995
5465717 Imran et al. Nov 1995
5472441 Edwards et al. Dec 1995
5505730 Edwards Apr 1996
5514130 Baker May 1996
5545161 Imran Aug 1996
5556396 Cohen et al. Sep 1996
5709224 Behl et al. Jan 1998
5810804 Gough et al. Sep 1998
5817092 Behl et al. Oct 1998
5827268 Laufer Oct 1998
5863290 Gough et al. Jan 1999
5868740 LaVeen et al. Feb 1999
5916235 Guglielmi Jun 1999
6036687 Laufer et al. Mar 2000
Foreign Referenced Citations (14)
Number Date Country
0 189 329 A2 Jul 1986 EP
0 629 382 A1 Dec 1994 EP
0 738 501 A1 Oct 1996 EP
WO9212681 Aug 1992 WO
WO 9321846 Nov 1993 WO
WO 9407446 Apr 1994 WO
WO 9421170 Sep 1994 WO
WO 9510322 Apr 1995 WO
WO 9510236 Apr 1995 WO
WO 9531142 Nov 1995 WO
WO 9632885 Oct 1996 WO
WO 9706739 Feb 1997 WO
WO 9717892 May 1997 WO
9855072 Dec 1998 WO
Non-Patent Literature Citations (12)
Entry
Electrofulgration of Varicous Veins, the Medical Letter on Drugs and Therapeutics, Jul. 12, 1968, at 53-55.
Watts, Endovenous Diathermy Destruction of Internal Saphenous, British Medical Journal, Oct. 7, 1972, p. 53.
O'Reilly, Endovenous Diathermy Sclerosis as a Unit of the Armanentarium for the Attack on Varicose Veins, The Medical Journal of Australia, Jun. 1, 1974, at 900.
O'Reilly, Endovenous Diathermy Sclerosis of Varicose Veins, The Australian New Zealand Journal of Surgery, vol. 47, No. 3, Jun. 1977, pp. 393-395.
Brunelle, et al., A Bipolar Electrode for Vascular Electrocoagulation with Alternating Current, Technical Notes, Oct. 1980, at 239-240.
O'Reilly, A Technique of Diathermy Sclerosis of Varicose Veins, The Australian New Zealand Journal of Surgery, vol. 51, No. 4, Aug. 1981, pp. 379-382.
Cragg et al., Endovascular Diathermic Vessel Occlusion, Diagnostic Radiology, 144:303-308, Jul. 1982.
Ogawa, et al., Electrothrombosis As a Treatment of Cirsoid Angioma in the Face and Scalp and Varicosis of the Leg, Plastic and Reconstructive Surgery, Sep. 1982, vol. 3, at 310-318.
Gradman, Venoscopic Obliteration of Variceal Tributaries Using Monopolar Electrocautery, Journal of Dermatology Surgery Oncology, 1994, 20, p. 482-485.
Inturri, Pathophysiology of Portal Hypertension, Journal of Vascular Technology 19 (5-6):271-276, Sep.-Dec. 1995.
Money, Endovascular Electroablation of Peripheral Veins, 22nd Annual Symposium, Current Critical Problems, New Horizons and Techniques in Vascular and Endovascular Surgery (Nov. 1995).
Crockett, et al., Preliminary Experience with an Endovascular Catheter for Electrocoagulation of Peripheral Veins, Journal of Vascular Technology, Winter 1996, at 19-22.